Insider Trading & Ownership - Belldegrun Arie

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Belldegrun Arie
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-01-12
Purchase		2022-01-14
12:02 pm		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		155,039$12.6$1,953,4917,075,233
(Indirect
Direct)		View
2020-06-04
Purchase		2020-06-04
4:04 pm		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		146,382$47$6,879,9546,447,492
(Indirect
Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-01-25
Option Award		2024-01-31
5:46 pm		N/A
2034-01-25		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		961,371$09,319,579
(Direct)		View
2023-09-07
Option Award		2023-09-08
3:43 pm		N/A
2033-09-07		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		10,000$010,000
(Direct)		View
2023-06-22
Option Award		2023-06-26
4:08 pm		N/A
2033-06-21		Kronos Bio Inc.KRONBelldegrun Arie
Director		34,000$034,000
(Direct)		View
2023-06-16
Option Award		2023-06-21
5:03 pm		N/A
N/A		Ginkgo Bioworks Holdings Inc.DNABelldegrun Arie
Director		245,123$0245,123
(Direct)		View
2023-03-22
Option Award		2023-03-24
8:14 pm		N/A
2033-03-22		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		2,277,776$09,353,008
(Direct)		View
2022-09-14
Exercise		2022-09-16
3:13 pm		N/A
N/A		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		160,000$5408,693
(Direct)		View
2022-09-14
Exercise		2022-09-16
3:13 pm		2019-10-07
2022-10-07		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		160,000$0408,693
(Direct)		View
2022-08-31
Exercise		2022-09-02
11:40 am		N/A
N/A		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		3,241$5248,693
(Direct)		View
2022-08-31
Exercise		2022-09-02
11:40 am		2015-09-01
2022-09-01		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		3,241$0248,693
(Direct)		View
2022-06-22
Option Award		2022-06-29
4:06 pm		N/A
2032-06-21		Kronos Bio Inc.KRONBelldegrun Arie
Director		34,000$034,000
(Direct)		View
2022-06-10
Option Award		2022-06-13
9:13 pm		N/A
2032-06-10		Ginkgo Bioworks Holdings Inc.DNABelldegrun Arie
Director		179,437$0698,178
(Direct)		View
2022-06-08
Option Award		2022-06-10
3:37 pm		N/A
2032-06-08		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		10,000$010,000
(Direct)		View
2022-03-14
Other(A)		2022-04-01
5:40 pm		N/A
N/A		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		4,710,120$014,502,270
(Indirect)		View
2022-03-14
Other		2022-03-31
5:27 pm		N/A
N/A		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		4,710,121$016,495,448
(Indirect)		View

Ownership(A)		2022-03-28
5:30 pm		N/A
N/A		Ginkgo Bioworks Holdings Inc.DNABelldegrun Arie
Director		0$0522,489
(Direct)		View
2022-03-23
Option Award		2022-03-25
5:50 pm		N/A
2032-03-23		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		1,458,333$01,458,333
(Direct)		View
2021-06-22
Option Award		2021-06-23
9:14 pm		N/A
2031-06-21		Kronos Bio Inc.KRONBelldegrun Arie
Director		20,600$020,600
(Direct)		View
2021-03-26
Exercise(A)		2021-06-09
1:47 pm		N/A
N/A		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		3,241$5245,452
(Direct)		View
2021-03-26
Exercise(A)		2021-06-09
1:47 pm		2014-07-27
2021-07-27		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		3,241$0245,452
(Direct)		View
2021-06-07
Option Award		2021-06-09
1:41 pm		N/A
2031-06-06		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		10,000$010,000
(Direct)		View
2021-05-24
Exercise		2021-05-25
08:00 am		N/A
N/A		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		379,066$18.226,920,193
(Direct)		View
2021-05-24
Exercise		2021-05-25
08:00 am		N/A
2030-03-18		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		379,066$06,920,193
(Direct)		View
2021-03-24
Exercise		2021-04-22
5:19 pm		N/A
N/A		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		3,241$5245,452
(Direct)		View
2021-03-24
Exercise		2021-04-22
5:19 pm		2014-07-27
2021-07-27		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		3,241$0245,452
(Direct)		View
2021-03-26
Option Award		2021-03-30
5:00 pm		N/A
2031-03-26		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		252,858$06,740,350
(Direct)		View
2020-10-14
Conversion		2020-10-16
3:44 pm		N/A
N/A		Kronos Bio Inc.KRONBelldegrun Arie
Director		8,932,028$02,315,314
(Indirect)		View
2020-10-14
Conversion		2020-10-16
3:44 pm		N/A
N/A		Kronos Bio Inc.KRONBelldegrun Arie
Director		253,251$16.152,315,314
(Indirect)		View

Ownership		2020-10-08
7:07 pm		N/A
N/A		Kronos Bio Inc.KRONBelldegrun Arie
Director
10% Owner		0$02,994,889
(Indirect)		View
2020-06-08
Option Award		2020-06-10
6:35 pm		N/A
2030-06-07		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		10,000$010,000
(Direct)		View
2020-03-18
Option Award		2020-03-20
4:38 pm		N/A
2030-03-17		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		379,066$0379,066
(Direct)		View
2019-06-03
Option Award		2019-06-05
4:52 pm		N/A
2029-06-02		UroGen Pharma Ltd.URGNBelldegrun Arie
Director		10,000$010,000
(Direct)		View
2019-05-13
Other		2019-05-15
5:10 pm		N/A
N/A		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		612,348$06,679,544
(Indirect)		View
2019-04-26
Other		2019-04-30
7:21 pm		N/A
N/A		Allogene Therapeutics Inc.ALLOBelldegrun Arie
Director		612,350$06,666,133
(Indirect)		View
(A) Indicate amendment filing.